X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Enterprise value to EBITDA ratio
Percentile
P60
Within normal range
vs 3Y Ago
-1.4x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -0.34 | +94.4% |
| 2024 | -6.16 | -440.4% |
| 2023 | -1.14 | -565.4% |
| 2022 | 0.24 | +331.3% |
| 2021 | -0.11 | +93.1% |
| 2020 | -1.53 | -322.3% |
| 2019 | -0.36 | -197.8% |
| 2018 | 0.37 | -65.3% |
| 2017 | 1.07 | +147.1% |
| 2016 | -2.27 | - |